Filter:
Search

TeleECHO Sessions

Live Interactive CME / CNE Webinars

 

Project ECHO® is a lifelong learning and guided practice model that revolutionizes online CME courses and exponentially increases workforce capacity to provide best-practice specialty care and reduce health disparities. The heart of the ECHO model™ is its expansive knowledge-sharing network, led by expert teams who use multi-point videoconferencing to conduct online CME courses and virtual clinics with community providers. In this way, ECHO®
allows CME providers to foster problem solving and interactive case discussion amongst doctors, nurses, and other clinicians, imparting invaluable insight to providing excellent specialty care to patients in their own communities.

The Project ECHO® format fosters dialogue in a way most online CME courses don’t and asking any questions you may have on the topic or a patient case in a HIPAA compliant manner is encouraged.

Updates and Best Practices Across Malignancies:
Evaluating Therapeutic Developments and Optimizing Multidisciplinary Care in Cutaneous Squamous Cell Carcinoma

This enduring educational activity focuses on leveraging targetable mutations for cancer-directed therapy, through evaluating approaches to tumor assessment as well as the latest developments in novel targeted and immune-therapeutic approaches. Learn more about potential immune targets, systemic treatment strategies, and optimizing multidisciplinary management to individualize care in cutaneous squamous cell carcinoma.

RELEASED DATE: August 10, 2023
EXPIRATION DATE: August 10, 2024

Learn More & View Event »

Applying the VA Preferred Care Roadmap: Front-Line Treatment of Advanced Non-small Cell Lung Cancer

This educational activity is designed to maintain an up-to-date understanding of the latest data on immune checkpoint inhibitor regimens in the management of NSCLC. We aim to discuss both the VA oncology clinical pathways and oncology precision program to guide personalized NSCLC care; evaluate immune checkpoint monotherapy clinical findings in the front-line treatment of patients with advanced NSCLC without targetable mutations; and examine the trials data for PD-1 inhibitor/chemotherapy combinations in the front-line management of patients with advanced NSCLC and no targetable mutations.

RELEASED DATE: August 15, 2023
EXPIRATION DATE: August 15, 2024

Learn More & View Event »

Factors Associated with Decision Making in the Second-Line Treatment of Patients with Advanced/Metastatic Gastrointestinal Cancers

This enduring educational activity focuses on the care of patients with advanced/metastatic gastric cancer and gastroesophageal junction adenocarcinoma. The program aims to help healthcare professionals improve their ability to evaluate which patient populations may benefit from anti-angiogenic therapy as a second-line treatment for advanced or metastatic gastric and gastroesophageal junction (GEJ) cancers, and to select appropriate second- and subsequent-line therapy based on clinical practice guidelines and the latest clinical trial findings.

RELEASED DATE: October 13, 2023
EXPIRATION DATE: November 28, 2024

Learn More & View Event »

Reshaping the Treatment Landscape in the Department of Veteran Affairs: Immunotherapy in Non-Melanoma Skin Cancer

This podcast series will focus on improving the ability of healthcare professionals (HCPs) to accurately assess recurrence risk in the patient with either basal cell carcinoma (BCC) or cutaneous squamous cell carcinoma (cSCC); increasing communication and coordination for the oncology team to optimize the care of high-risk patients with appropriate use of immune checkpoint therapy in NMSC; and ensuring the consistent application of evidence-based oncology recommendations for patients with either BCC or cSCC for clinicians treating NMSC within the Department of Veterans Affairs.

RELEASED DATE: January 02, 2024
EXPIRATION DATE: January 02, 2025

Learn More & View Event »

Relief in Sight: Understanding the Burden of Spondyloarthritis Conditions and Improving Outcomes

In this series of two podcasts, Dr. Alexis Ogdie will discuss the clinical manifestations of spondyloarthritis in order to differentiate it from other pain-related conditions. This includes discussion of the differences between axial spondyloarthritis and peripheral spondyloarthritis. In addition, Dr. Ogdie will discuss treatment strategies, both novel and conventional, and describe the importance of shared decision-making and multidisciplinary collaboration in pursuing the best treatment outcomes.

RELEASED DATE: January 12, 2024
EXPIRATION DATE: January 12, 2025

Learn More & View Event »

Key Updates in Bispecific Antibodies in NHL Management—Unmet Needs and Opportunities for Improved Management in Later-Line Management

This enduring TeleECHO educational series is designed to assist members of the multi-disciplinary oncology care team in identifying approaches to the use of novel bispecific antibody therapies in later-line management of B-cell non-Hodgkin’s lymphoma (NHL). This program features expert analysis of the latest clinical trial outcomes and potential adverse events associated with bispecific antibody therapy, as well as discussion of best practices for multidisciplinary management of B-cell NHL to improve long-term clinical outcomes.

RELEASED DATE: January 26, 2024
EXPIRATION DATE: January 26, 2025

Learn More & View Event »
Scroll to Top

A Special Thank You to All HCPs

Med Learning Group sends its heartful gratitude to all healthcare professionals giving their all, 24/7, during this pandemic, despite the great risks they face. We cannot thank you enough for your courage and selfless service.

Connecting you with our personalized approach to continuing Medical Education

Healthcare Business Review Award

We are thrilled to announce that we have been recognized as one of the Top 10 Health Education Services Providers by Healthcare Business Review!

This award is both an honor and a testament to our cumulative dedication to providing the best continuing medical education (CME) services to HCPs across the globe. We are proud to be part of this distinguished group and look forward to continuing to have MLG be one of the best CME providers in the country.

Thank you to Healthcare Business Review for this recognition and for shining a light on the importance of accurate and accessible healthcare education.

#TopHealthEducationProvider #MedLearningGroup #HealthcareBusinessReview #MedicalEducation
BestofAmerica

Best of America Small Business Awards
Best Website

The Best of America Small Business Website award recognizes the best website launched by a small business since 2021. Technology is a key growth enabler for small businesses. The best in tech track recognizes small businesses as experts in technology and innovation from innovators, app developers, and website creators. Visit our award-winning Ophthalmology and Optometry web portal: vision-relief.com

The Linking Approach to Education from Gap Analysis to Outcomes

Med Learning Group, a division of Ultimate Medical Academy, is a full-service accredited medical education company with commendation. Med Learning Group focuses on developing and implementing continuing education that improves healthcare practitioners’ ability to provide optimal care to their patients. Our goal is to provide high-quality education that is designed to deliver the highest level of outcomes for not only the practitioner, but also the patient. Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature.

Med Learning Group has expertise in developing both live and online activities that are innovative, case-based, interactive and patient-centric in nature, and we focus on applying adult learning theory and principles to our programs. Even more importantly, we understand the nuances of our target audiences and design programs with a grounded understanding of how to educate both specialty audiences and general practitioners.